2-(5-H/Cl/Me/NO2-1H-benzimidazol-2-yl)-4-Me/Br-phenols (HL1-HL5) were synthesized. HL1 complexes with Cu(NO3)2, AgNO3, Zn(ClO4)2 and; HL4, HL5 complexes with Zn(ClO4)2 were prepared. The structures of the compounds were confirmed on the basis of elemental analysis, molar conductivity, magnetic moment, FT-IR, 1 H-and 13 C-NMR. Antibacterial activity of the ligands and the complexes were evaluated using the disk diffusion method in dimethyl sulfoxide (DMSO) as well as the minimal inhibitory concentration (MIC) dilution method, against nine bacteria, and the results were compared with penicillin-G and oxytetracycline. While HL1 ligand has considerable antibacterial activity on B. cereus only; it's Ag(I) complex show antibacterial effect toward almost all the bacteria. It is highly interesting that HL5 and [Zn(HL5)(L5)]ClO4 exhibit considerable high antibacterial activity toward K. pneumoniae, B. cereus, S. epidermidis and B. subtilis.
INTRODUCTION
It was reported that many benzimidazolylphenol derivatives and their metal complexes exhibit various antimicrobial activities. For example, some benzimidazolyl-phenol type ligands and their Fe(III) complexes showed broad spectrum of antimicrobial activity that were either more active or equipotent as the references [1, 2] . Co(II) and Ni(II) chelates of 2-(2´-hydroxyphenyl)benzimidazole have antifungal activity against Alternaria alternata and Aspergillus niger [3, 4] . Fe(III), Ag(I) and Hg(II) complexes of some 5-substituted 2-(2´-hydroxyphenyl)-1Hbenzimidazoles showed antibacterial and antifungal effects [5] .
In our previous works, antimicrobial activity of various 1H-benzimidazol-2-yl-phenol derivatives and their some transition metal complexes was investigated. It was reported that 2methoxy-6-(5-H/chloro-1H-benzimidazol-2-yl)-phenols and Cu(II), Zn(II) complexes exhibit antibacterial activity against gram positive bacteria [6] . 4-Methoxy-2-(1H-benzimidazol-2-yl)phenol and its Ag(I) and Cu(II) complexes were effective on S. epidermidis, S. aureus and B. subtilis.
Also, 4-methoxy-2-(5-methyl/chloro-1H-benzimidazol-2-yl)-phenols display antibacterial activity toward S. aureus [7] . It was noticed that while 2-methyl-6-(1Hbenzimidazol-2-yl)-phenol had no any activity, it's Ag(I) and Zn(II) complexes demonstrate antibacterial effect toward K. pneumoniae, S. epidermidis and S. aureus bacteria [8] . 2-(5-Nitro-1H-benzimidazol-2-yl)-4-bromophenol and its Cu(II), Fe(III) complexes show considerable antibacterial activity against S. epidermidis as compared to ciprofloxazin [9] .
In this study, 2-(5-H/Cl/Me/NO 2 -1H-benzimidazol-2-yl)-4-Me/Br-phenols (HL 1 -HL 5 , Figure  1 
EXPERIMENTAL

Materials and apparatus
All chemicals and solvents were of reagent grade (Merck, Fluka and Sigma-Aldrich) and were used without further purification. Melting points were determined using a Gallenkamp melting point apparatus (The Netherlands). C,H,N content was determined on a Thermo Finnigan Flash EA 1112 analyzer (USA-Thermo Fisher Scientific). Molar conductivity of the complexes was measured on a WTW Cond315i conductivity meter (USA-Nova Analytics) in DMSO at 25 ± 1 ºC. 1 H-and 13 C-NMR spectra were run on a Varian Unity Inova 500 NMR spectrometer (USA) in DMSO-d 6 . 13 C-NMR spectra were recorded as attached proton test (APT). The residual DMSO-d 6 signal was used as an internal reference. FT-IR spectra were recorded in KBr disks on a Nicolet 380 FT-IR spectrometer (Thermo Fisher Scientific, USA). Magnetic moment measurement of Cu(II) complex was carried out on a Sherwood Scientific apparatus (UK) at room temperature by Gouy's method using CuSO 4 ·5H 2 O as the calibrant and were corrected for diamagnetism by applying Pascal's constants.
Synthesis of the ligands
The ligands were prepared according to literature procedures [10, 11] , by reacting 2-hydroxy-5methyl-benzaldehyde (1.36 g, 10 mmol) and an equivalent amount of NaHSO 3 (1.04 g, 10 mmol) at room temperature in ethanol (25 mL) for 4-5 hours. For 2-(5-chloro-1H-benzimidazol-2-yl)-4-methylphenol (HL 3 ) synthesis, this mixture was treated with 4-chloro-1,2phenylenediamine (1.42 g, 10 mmol) in dimethylformamide (15 mL) and gently refluxed for 2 hours. The reaction mixture was then poured into iced water (500 mL), filtered and crystallized from ethanol. The other ligands were prepared in a similar manner to ligand HL 3 .
Syntheses of the complexes
The synthesis procedures of the complexes are given below.
[ Qualitative antibacterial evaluation. Disc diffusion method was used for the detection of the antibacterial effect of the chemical agents qualitatively [12] . For this purpose, filter papers (Whatman No. 1) with 6 mm diameter were autoclaved and dried at 37 °C for overnight. Each chemical agent (21.27 mg) was dissolved in DMSO and 23.5 µL of this solution (containing 500 µg chemical agent) were soaked on to the sterile discs. Bacterial suspension with 1-2 x 10 8 cfu/mL (McFarland 0.5) were prepared from each bacterial strain and streaked onto the agar, chemical agents impregnated discs were placed onto the agar surface and incubated at 37 °C for 24 h. Chemical agents with growth inhibition zones were used for the further examinations.
Quantitative antibacterial evaluation. For the detection of the antibacterial effect of the chemical agents, quantitatively, macro dilution broth method according to Clinical and Laboratory Standards Institute (formerly NCCLS) were performed [13] . Serial dilutions of the chemical agents between 531.75-0.26 µg/mL with CAMBH were prepared within sterile tubes. Bacterial suspension with 10 7 cfu/mL final concentration was inoculated. Positive (without tested chemical agent) and negative (without bacterial suspension) tubes were used at the end of the each organism tested. Tubes were incubated at 37 °C for 24 h. The MIC value was defined as the lowest concentration of the chemical agent giving complete inhibition of visible growth.
RESULTS AND DISCUSSION
Physical properties
The analytical data and physical properties of the ligands and the complexes are summarized in Table 1 . The melting points of the ligands HL 2 -HL 5 suggested that the methyl substitution on 5position of the benzimidazole moiety decreases the melting point, and chlorine atom increases it with respect to HL 1 ligand. Also, bromo substituent on 4'-position of the phenol moiety increases the melting point.
Molar conductivity values of the Ag(I) and Zn(II) complexes of HL 1 were 45 and 56 Ω -1 cm 2 mol -1 , respectively. These results are indicative for 1:1 electrolytes. The other complexes have non-ionic character according to the molar conductivity values [14, 15] .
Magnetic moment value of [Cu(L 1 ) 2 ]·3H 2 O complex was 1.61 BM at room temperature, which is close to the spin value for only one unpaired electron. It is consistent with a square planar structure of Cu(II) complex [16] [17] [18] .
Zn(II) complexes of HL 4 and HL 5 ligands have 1:2 M:L ratio. According to the analytical and spectral data, these complexes may have the structure as [Zn(HL)(L)]ClO 4 in which a hydroxy proton of one of the ligands is removed whereas the others' is not on complexation.
There is a similar structure reported in the literature by Tong and Ye [19] . 
FT-IR spectra
FT-IR spectral data of the ligands and the complexes are given in Table 2 . In the IR spectra of HL 1 , the bands at 3330 and 3284 cm -1 are due to OH and NH stretching vibration frequencies, respectively. These bands appear closer to each other due to intramolecular hydrogen bonding between the phenoxy hydrogen atom and one of the imine nitrogen atoms [2, 20, 21] . These bands change significantly upon metal complexation indicating deprotonation and subsequent involvement of the phenoxy group in metal coordination.
In the other ligands (HL 2 -HL 5 ), the characteristic ν(O-H) and ν(N-H) vibration frequencies exhibit only a single strong band at ca. 3300 cm -1 in their IR spectra, caused by double intramolecular hydrogen bonding between the phenoxy hydrogen atom and one of the imine nitrogen atoms (Table 2, Figure 2 ). This band of HL 4 and HL 5 spectra shifted significantly upon Zn(II) complexation indicating deprotonation and subsequent involvement of the phenoxy group. In the spectra of all the compounds, the characteristic ν(C-H) and δ(C-H) modes of ring residues were observed in the region 3038-3110 cm -1 and 843-731 cm -1 , respectively ( Table 2) . The weak or medium bands near 2920 cm -1 at the spectra of HL 1 , HL 2 , HL 3 ligands and HL 1 complexes are due to stretching vibrations of the methyl group or groups.
The ν(C=C) frequencies for the benzimidazole and phenol rings are expected to appear at ca. 1620 cm -1 with their own characteristics for the ligands in the IR spectra. These frequencies shift to the higher frequency upon complex formation. Similarly the (C=N) asymmetric stretching frequencies are expected to appear at ca. 1590 cm -1 [2, 11] . Thus, the IR band, at 1593 cm -1 in HL 1 ligand, shifts to the higher frequencies of 1600 cm -1 for the complexes. These frequency changes may support the argument that coordination possibly occurs via imine nitrogen atom.
Ag(I) complex showed a strong band at 1385 cm -1 in the IR spectra, supporting the presence of uncoordinated nitrate ion, which was also confirmed by conductivity data [22, 23] . Zn(II) complexes have strong bands around 1110 cm -1 can be assigned to the stretching vibrations of the uncoordinated perchlorate anion Cl-O [24, 25] . Cu(II) and Zn(II) complexes of HL 1 have broad bands at 3431 and 3459 cm -1 , respectively, can be attributed to ν(H 2 O).
NMR spectra
1 H-NMR spectral data of the ligands and the Zn(II) complexes, and the assignments of the peaks are present in Table 3 . The HL 1 ligand gives two singlets at 13.12 and 12.86 ppm for NH and OH protons, respectively. These signals are very closer to each other because of intra-molecular hydrogen bonding between the OH hydrogen and the C=N nitrogen atoms.
According to the 1 H-NMR spectra, HL 2 has two isomeric forms (Figures 3 and 4 , Table 3 ). The isomeric structures are observed for the benzimidazole protons only. The isomerism could theoretically occur for HL 3 , HL 4 and HL 5 , also. However, isomerism was not observed for these compounds. Reason of this may be the methyl substituent, an electron donating group, at 5position of benzimidazole moiety of HL 2 . On the other hand, HL 3 , HL 4 and HL 5 have electron withdrawing groups at the same position, Cl, Cl and NO 2 , respectively. The isomerism occurs in only HL 2 ligand probably due to presence of an electropositive group at 5-position of benzimidazole moiety of HL 2 as a difference from the others. In the 1 H-NMR spectra of the Zn(II) complexes, some prominent changes were observed in the characteristics regions of the phenolic and benzimidazole benzene ring protons with respect to the ligands. For instance, in the spectra of [Zn(L 1 )(H 2 O) 2 ]ClO 4 complex, multiplet and doublets change to broad singlets or broad doublets because of the metal ion's strong perturbing effect. It can be said that, on complexation, acidic character of the benzimidazole and the phenol moiety protons is increased.
The OH proton signal in the 1 H-NMR spectra of the Zn(II) complexes was removed as expected. This observation is an evidence for the OH hydrogen's eliminating and the phenolic oxygen's coordinating to the Zn(II) ion ( Figure 5 ). The protons of the methyl group at the benzimidazole moiety gave a singlet at 2.46 ppm while the methyl group at the phenol ring appeared at 2.32 ppm in the 1 H-NMR spectra of HL 2 which included two methyl groups. 13 C-NMR (attached proton test, APT) spectral data of the ligands and the Ag(I) and Zn(II) complexes are given in Table 4 . In the APT spectra of HL 1 Table 4 . 
Antibacterial activity
The results concerning in vitro antibacterial activity of the ligands and the complexes together with the inhibition zone (mm) and MIC values (µg/mL) are presented in Tables 5 and 6 , respectively.
As can be seen from Tables 5 and 6 , [Ag(HL 1 ) 2 ]NO 3 complex shows considerable antibacterial effect (higher than that of oxytetracycline) toward all the bacteria except P. mirabilis. It is remarkable that HL 5 exhibits superior activity especially against K. pneumoniae, B. cereus and S. epidermidis while HL 2 and HL 4 have no any activity on the bacteria. In addition, Zn(II) complex of HL 5 shows higher antibacterial effect on also B. subtilis besides these three bacteria: 1.04, 2.08, 1.04 and 4.15 µg mL -1 , respectively. Similarly, Zn(II) complex of HL 4 was effective on these four bacteria (K. pneumoniae, B. cereus, S. epidermidis and B. subtilis) when the ligand itself has no any activity. On the other hand, [Zn(L 1 )(H 2 O) 2 ]ClO 4 exhibited weak antibacterial effect on E. coli, K. pneumoniae and S. aureus that HL 1 ligand has no any effect on them. − a − − − − 10 5 All these results show that Zn(II) ion in the complexes increases the antibacterial effect. HL 5 , includes bromo and nitro substituents, has higher antibacterial activity than the other ligands. On the other hand, it can be said that antibacterial activity of the Zn(II) complexes is more effective on gram(+) bacteria as compared to gram(-) bacteria (selective activity).
Superior activities of HL 5 ligand and [Zn(HL 5 )(L 5 )]ClO 4 complex against four bacteria, K. pneumoniae, B. cereus, S. epidermidis and B. subtilis, are considered to be valuable contribution to the researches on metal-based drugs field. The results of our study indicated that the compounds, particularly such as [Ag(HL 1 ) 2 ]NO 3, HL 5 and [Zn(HL 5 )(L 5 )]ClO 4 have the potential to generate novel metabolites, by displaying high affinities towards various receptors.
